Form D · Biotechnology

REGEN BIOLOGICS INC

Hackensack, NJ · CIK 0000883697

Offering snapshot reported Feb 27, 2009 · SEC filing

Reported sold
$1.7M
Offering amount: $1.7M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 27, 2009Initial$1,700,000No comparisonNot reportedSEC filing
Jan 30, 2009Initial$7,051,572No comparisonNot reportedSEC filing
Dec 16, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Aug 11, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-88369-7P

Source: Form D, filed Feb 27, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Abhi Acharya Director
Alan W. Baldwin Director
Gerald E. Bisbee, Jr. Director, Executive
Jeffrey Chandler Executive
John Dichiara Executive
James Flounlacker Executive
Robert G. Mc Neil Director
William G. Rodkey Executive
J. Richard Steadman Director
William R. Timken Director
Brion D. Umidi Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
411 Hackensack Avenue 10 Th Floor
Hackensack, NJ, 07601